Infection with certain types of HPV, the so-called “oncogenic HPVs” including 16, 18, 31, 33, and 35, has been associated as a major risk factor in the subsequent development of cervical cancer. The high-risk HPV 16 group is almost equally associated with cervical intraepithelial neoplasia (CIN) and cervical cancer. HPV 6 and 11 are found mainly in benign cervical lesions while HPV 16 and 18 have been associated with premalignant and malignant cervical lesions. The presence of HPV has been reported in malignant lesions of the skin, oral cavity, tongue, and lung. This antibody Papillomarvirus type 16 in the nucleus of infected cells or tissues stained by immunohistochemical techniques.
| Intended Use | IVD |
|---|---|
| Antibody Type | Monoclonal |
| Clone | Cam Vir-1 |
| Source | Mouse |
| Tissue Type/Cancer Type | Hpv Inf |
| Pack | 0.5 mL – Manual – Concentrate, 1 mL – Manual – Concentrate, 6 mL – Manual – RTU, 50 Tests – Automation – Xmatrx, 100 Tests – Automation – i6000, 160 Tests – Automation – Xmatrx, 5 slides – Xmatrx, 5 slides – Manual |
